---
title: "ASIET: Has completed the research and development of a highly reliable RISC-V processor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251404990.md"
description: "On August 4th, ASIET stated on the interactive platform that the company has completed the research and development of a highly reliable RISC-V processor and is currently conducting product testing and validation"
datetime: "2025-08-04T08:17:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251404990.md)
  - [en](https://longbridge.com/en/news/251404990.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251404990.md)
generator: "portal-rs"
---

# ASIET: Has completed the research and development of a highly reliable RISC-V processor

On August 4th, ASIET stated on the interactive platform that the company has completed the research and development of a highly reliable RISC-V processor and is currently conducting product testing and validation

### Related Stocks

- [300455.CN](https://longbridge.com/en/quote/300455.CN.md)

## Related News & Research

- [Heart Aerospace Just Flew The Aviation Transition Investors Should Be Putting Billions Into](https://longbridge.com/en/news/296674386.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [PMGC unit NorthStrive Biosciences files US patents for EL-22, EL-32 to curb microgravity muscle loss](https://longbridge.com/en/news/296624370.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**